Skip to content
10-Q

Quarterly Report

Pelthos Therapeutics Inc. PTHS

0001753926-25-001764

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 3.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 579.23K sh
Shares Diluted Q3 2025 · Sep 30, 2024 542.04K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.34M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$5.12M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $14.2M
Stockholders Equity Q3 2025 · Sep 30, 2025 $58.25M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$6.49M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$4.2M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.71M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$1.43M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$184K
Stockholders Equity restated Q3 2025 · Mar 31, 2024 $1.13M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$6.45M
Current Liabilities Q3 2025 · Sep 30, 2025 $24.77M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.08M
Total Liabilities Q3 2025 · Sep 30, 2025 $68.18M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.08M
Current Assets Q3 2025 · Sep 30, 2025 $49.76M
Current Assets Q3 2025 · Dec 31, 2024 $1.37M
Total Assets Q3 2025 · Sep 30, 2025 $126.43M
Total Assets Q3 2025 · Dec 31, 2024 $1.37M
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$14.96
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.93
Eps Diluted Q3 2025 · Sep 30, 2024 −$11.12
Eps Basic Q3 2025 · Sep 30, 2025 −$5.30
Eps Basic Q3 2025 · Sep 30, 2025 −$14.96
Eps Basic restated Q3 2025 · Sep 30, 2024 −$2.93
Eps Basic restated Q3 2025 · Sep 30, 2024 −$11.12
Sga Expense Q3 2025 · Sep 30, 2025 $19.63M
Sga Expense Q3 2025 · Sep 30, 2025 $23.98M
Sga Expense Q3 2025 · Sep 30, 2024 $1.63M
Sga Expense Q3 2025 · Sep 30, 2024 $4.85M
Rd Expense Q3 2025 · Sep 30, 2025 $145K
Rd Expense Q3 2025 · Sep 30, 2025 $854K
Rd Expense restated Q3 2025 · Sep 30, 2024 $415K
Rd Expense restated Q3 2025 · Sep 30, 2024 $894K
Net Income Q3 2025 · Sep 30, 2025 −$16.24M
Net Income Q3 2025 · Sep 30, 2025 −$21.66M
Net Income Q3 2025 · Jun 30, 2025 −$3.45M
Net Income Q3 2025 · Mar 31, 2025 −$1.97M
Net Income restated Q3 2025 · Sep 30, 2024 −$1.7M
Net Income restated Q3 2025 · Sep 30, 2024 −$6.03M
Net Income restated Q3 2025 · Jun 30, 2024 −$1.77M
Net Income restated Q3 2025 · Mar 31, 2024 −$2.56M
Operating Income Q3 2025 · Sep 30, 2025 −$15.36M
Operating Income Q3 2025 · Sep 30, 2025 −$20.43M
Operating Income restated Q3 2025 · Sep 30, 2024 −$2.05M
Operating Income restated Q3 2025 · Sep 30, 2024 −$5.75M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.32M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.32M
Revenue Q3 2025 · Sep 30, 2025 $294K
Revenue Q3 2025 · Sep 30, 2025 $294K